Isothiazolidines useful in the treatment of ocular hypertensive conditions

Details for Australian Patent Application No. 2007249443 (hide)

Owner Allergan, Inc.

Inventors Old, David W.; Burk, Robert M.; Gac, Todd S.

Agent Davies Collison Cave

Pub. Number AU-B-2007249443

PCT Pub. Number WO2007/134085

Priority 60/747,115 12.05.06 US; 11/745,317 07.05.07 US

Filing date 9 May 2007

Wipo publication date 22 November 2007

Acceptance publication date 27 September 2012

International Classifications

C07D 275/06 Heterocyclic compounds having nitrogen and sulfur as the only ring hetero atoms

A61K 31/425 - Thiazoles

A61P 9/12 Drugs for disorders of the cardiovascular system

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 471/06 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

11 December 2008 PCT application entered the National Phase

  PCT publication WO2007/134085 Priority application(s): WO2007/134085

27 September 2012 Application Accepted

  Published as AU-B-2007249443

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007249452-High flux and selectivity SAPO-34 membranes for CO2/CH4 separations

2007249435-5 HT receptor mediated neurogenesis